Events

- MAR 21 2019
Abstracts to be Presented at AACR 2019
Oncoceutics, Inc. and its commercial and academic collaborators will be presenting multiple abstracts at the 2019 annual meeting of the American Association for Cancer Research in Atlanta, Georgia, on March 29th to April 3rd. These abstracts will highlight ONC201’s unique mechanism of action, various single agent and combination data, and characterization of other imipridones, including

Read >
- NOV 19 2018
ONC201 Advocacy Meeting at SNO 2018 – New Orleans, November 17, 2018
Advocacy Meeting – Oncoceutics, a clinical-stage drug discovery and development company. Looking forward to hearing about what's fresh and new! And who says SNO meetings aren't fun??? Check out THESE faces! 😉 #SNO2018 #endbraincancer pic.twitter.com/uSOUadi3qN — End Brain Cancer Initiative (@EndBrainCancer) November 17, 2018

Read >

Lee Schalop, COO of Oncoceutics to present at Jefferies Healthcare Conference on June 7 at 10:00am